Anti-Hypertensive Biprel (Perindopril Erbumine/Indapamide) Now Available In Canada
Unregistered User
If this is not your name, click here.
Contact Us | Order Now | Journals | Bookstore | Register a colleague
 
  SEARCH  
News
Bookstore
Medline
The Web
Meetings & Congresses
Complete Doctor's Guide
 


 EXPLORE :
 news  All News
 webcasts All Webcasts
 All cases All Cases
 Meetings All Meetings & Congresses
 Medical All Medical Resources

top





New drugs / indications

English Dictionary

Medical Dictionary

Thesaurus



Warning | Privacy | Awards



 Favourite Journals 

Click here to choose your favourite journals


 Favourite Sites 

Click here to choose your favourite sites


 Languages 



  




Anti-Hypertensive Biprel (Perindopril Erbumine/Indapamide) Now Available In Canada

MONTREAL, QC -- January 17, 2003 -- Servier Canada Inc. is pleased to announce that New (pR) Biprel® (perindopril erbumine 4 mg/ indapamide 1.25 mg) is now available in Canada. Biprel is the only combination anti-hypertensive offering the benefits of both Coversyl® and Lozide®. A once-daily fixed- dose tablet, Biprel combines the benefits of an ACE Inhibitor with a diuretic which act synergistically for excellent blood pressure control.(1,2) Biprel is indicated for the treatment of mild to moderate essential hypertension in patients for whom combination therapy is appropriate.

According to the Heart and Stroke Foundation, one out of five Canadians has high blood pressure.(3) And almost two-thirds of patients require multiple treatment agents to achieve blood pressure control.(4) Biprel is an important new treatment option that offers the benefits of a two-in-one tablet and provides patients with a new choice to help manage their hypertension more effectively both from a compliance and cost perspective.

In a recent multi-center, randomized, double-blind, parallel-group study, Biprel was shown to be equally as effective as the combination of enalapril 20mg/hydrochlorothiazide 12.5 mg with reductions of diastolic blood pressure of -13.1 mmHg and -14.2mmHg respectively.(2)

ACE Inhibitors and Diuretics

Despite what some Canadians may think, high blood pressure gives almost no warnings. In fact, close to half the people who have it don't know they do. When high blood pressure is left untreated, it can lead to heart disease, stroke and kidney disease.

ACE inhibitors belong to a family of drugs known as "vasodilators". Vasodilators help the blood vessels to relax and dilate (open up). By relaxing the blood vessels, ACE inhibitors reduce blood pressure and decrease the effort and workload of the heart.

Diuretics (commonly known as "water pills") work on the kidneys to produce more urine. By decreasing water and salt in the body, they lower blood pressure and help reduce the workload on the heart.

Servier Canada Inc. is a pharmaceutical company located in Laval, Quebec that focuses on the development of therapies to treat cardiovascular, metabolic and CNS diseases. In the cardiovascular sector, Servier research has acquired unrivalled experience and international renown. Servier is the only company in the world to deploy a modern and extensive range of cardiovascular products all derived from its own research.

References:
(1)Myers MG, Asmar R, Leenen FHH et al. Fixed low-dose combination therapy in hypertension - a dose response study of perindopril and indapamide. Journal of Hypertension 2000; Vol 18(3):317-325.
(2)Luccioni R, Sever PS, Di Perri T et al. An equivalence study of the safety and efficacy of a fixed-dose combination of perindopril with indapamide versus fixed-dose combinations of captopril with hydrochlorothiazide and enalapril with hydrochlorothiazide in the treatment of hypertension. Journal of Hypertension 1995, Vol 13:1847-1851.
(3)Heart and stroke Foundation online: http://www.heartandstroke.ca
(4)Hansson L, Zanchetti A, Carruthers SG et al. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the hypertension optimal treatment (HOT) randomised trial. Lancet 1998; 351:1755-62.

SOURCE: Servier Canada Inc.,

E-mail this page
to a friend or colleague!
To print,
use this version




Any question regarding a medical diagnosis, treatment, referral, drug availability or pricing should be directed to either a licensed physician or to the product's manufacturer.

If you have any technical questions or other concerns about this site, feel free to contact us at webmaster@docguide.com.

All contents Copyright (c) 1995- Doctor's Guide Publishing Limited. All rights reserved.


Employment opportunities | Partnering opportunities